Noul Co.,Ltd. (KOSDAQ:376930)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,594.00
-62.00 (-3.74%)
At close: Mar 6, 2026
-45.60%
Market Cap 81.76B
Revenue (ttm) 3.91B
Net Income (ttm) -20.20B
Shares Out 51.29M
EPS (ttm) -546.77
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 459,594
Average Volume 588,704
Open 1,656.00
Previous Close 1,656.00
Day's Range 1,540.00 - 1,698.00
52-Week Range 1,418.00 - 4,190.00
Beta -0.55
RSI 35.73
Earnings Date Mar 20, 2026

About Noul Co.,Ltd.

Noul Co.,Ltd. engages in the in-vitro diagnosis and remote diagnosis business worldwide. It offers miLab, an AI-based blood diagnostic medical device that automates sample preparation, imaging, and analysis. The company also provides malaria diagnostics, blood cell morphology analysis, cancer morphology, immunohistochemistry services, and digital cervical cell analysis solution. Noul Co.,Ltd. was incorporated in 2015 and is headquartered in Yongin-si, South Korea. [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 2015
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 376930
Full Company Profile

Financial Performance

In 2024, Noul Co.,Ltd.'s revenue was 1.60 billion, a decrease of -41.42% compared to the previous year's 2.73 billion. Losses were -22.47 billion, 37.7% more than in 2023.

Financial Statements

News

There is no news available yet.